Armata Pharmaceuticals, Inc. — Director's Dealing 2005

Aug 16, 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2005-08-15

Reporting Person: HAWLEY ROGER (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2005-08-15	Stock Option (right to buy)	$0.69	A	60000	Acquired	2015-08-15	Common Stock (60000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities held	0	Direct

Footnotes

F1: Such option vests and is exercisable as follows: 33.33% on each of August 15, 2006, August 15, 2007 and August 15, 2008.

F2: Price is not applicable.